Potential coronavirus vaccines currently being developed a major drug manufacturer and its corporate partner have been granted “fast track” approval by the Food and Drug Administration (FDA), Reuters reported. The designation could potentially mean that a vaccine gets produced and deployed sooner than would otherwise be required of a new drug.
Pharmaceutical giant Pfizer and its partner, BioNTech, have been working to get a coronavirus vaccine, as have multiple other drug manufacturers in the U.S. and abroad. In the case of Pfizer, two potential candidates seem to show promise: BNT162b1 and BNT162b2. Specifically, in ongoing clinical trials being carried out in the U.S. and in Germany, test subjects had more COVID-19 antibodies in their system after 28 days than typically seen in people who were infected with the coronavirus.
The manufacturers hope to expand their clinical trials in the coming month to include as many as 30,000 participants.
0 comments :
Post a Comment